Complexes of form L2MX
9 claims: 6 independent, 3 dependent
- 1Use of a phosphorescent compound having the formula L 2 MX as a phosphorescent emitter in an organic light emitting device, wherein:M is a metal that forms octahedral complexes;L is a monoanionic bidentate ligand, which is bonded to M through an sp 2 hybridized carbon and a heteroatom;X is a monoanionic bidentate ligand;and L and X are inequivalent.
- 4The use of any one of the previous claims, wherein emission from the X ligand can be observed.
- 5The use of any one of the previous claims, wherein X is capable of trapping electrons or holes.
- 6The use of any one of the previous claims, wherein the X ligand comprises acetylacetonate.
- 8The use of any one of the previous claims, wherein the organic light emitting device is incorporated into a system selected from the group of systems consisting of a vehicle, a computer, a television, a printer, a large area wall, a billboard, a stadium screen, a theater screen and a sign.
- 9The use of any one of the previous claims, wherein the phosphorescent compound having the formula L 2 MX is used in an emissive layer of an organic light emitting device.
Independent claims6
138 paragraphs in 1 section, as filed
<u>I. FIELD OF INVENTION</u>
The present invention relates to the use of organometallic compounds of formula L<sub>2</sub>MX as a phosphorescent emitter in organic light emitting devices, wherein L and X are distinct bidentate ligands, and M is a metal, especially iridium, their synthesis and use as dopants in certain hosts to form an emitting layer in organic light emitting devices.
<u>II. BACKGROUND OF THE INVENTION</u>
II. A. General Background
Organic light emitting devices (OLEDs) are comprised of several organic layers in which one of the layers is comprised of an organic material that can be made to electroluminesce by applying a voltage across the device, <nplcit id="ncit0001" npl-type="s"><text>C.W. Tang et al., Appl. Phys. Lett. 1987, 51, 913</text></nplcit>. Certain OLEDs have been shown to have sufficient brightness, range of color and operating lifetimes for use as a practical alternative technology to LCD-based full color flat-panel displays (<nplcit id="ncit0002" npl-type="s"><text>S.R. Forrest, P.E. Burrows and M.E. Thompson, Laser Focus World, Feb. 1995</text></nplcit>). Since many of the thin organic films used in such devices are transparent in the visible spectral region, they allow for the realization of a completely new type of display pixel in which red (R), green (G), and blue (B) emitting OLEDs are placed in a vertically stacked geometry to provide a simple fabrication process, a small R-G-B pixel size, and a large fill factor, International Patent Application No. <patcit id="pcit0001" dnum="US9515790W" dnum-type="L"><text>PCT/US95/15790</text></patcit>.
A transparent OLED (TOLED), which represents a significant step toward realizing high resolution, independently addressable stacked R-G-B pixels, was reported in International Patent Application No. <patcit id="pcit0002" dnum="US9702681W" dnum-type="L"><text>PCT/US97/02681</text></patcit> in which the TOLED had greater than 71% transparency when turned off and emitted light from both top and bottom device surfaces with high efficiency (approaching 1% quantum efficiency) when the device was turned on. The TOLED used transparent indium tin oxide (ITO) as the hole-injecting electrode and a Mg-Ag-ITO electrode layer for electron-injection. A device was disclosed in which the ITO side of the Mg-Ag-ITO layer was used as a hole-injecting contact for a second, different color-emitting OLED stacked on top of the TOLED. Each layer in the stacked OLED (SOLED) was independently addressable and emitted its own characteristic color. This colored emission could be transmitted through the adjacently stacked, transparent, independently addressable, organic layer or layers, the transparent contacts and the glass substrate, thus allowing the device to emit any color that could be produced by varying the relative output of the red and blue color-emitting layers.
<patcit id="pcit0003" dnum="US9515790W" dnum-type="L"><text>PCT/US95/15790</text></patcit> application disclosed an integrated SOLED for which both intensity and color could be independently varied and controlled with external power supplies in a color tunable display device. The <patcit id="pcit0004" dnum="US9515790W" dnum-type="L"><text>PCT/US95/15790</text></patcit> application, thus, illustrates a principle for achieving integrated, full color pixels that provide high image resolution, which is made possible by the compact pixel size. Furthermore, relatively low cost fabrication techniques, as compared with prior art methods, may be utilized for making such devices.
II.B. Background of emission
II.B.1. Basics
II.B.1.a. Singlet and Triplet Excitons
Because light is generated in organic materials from the decay of molecular excited states or excitons, understanding their properties and interactions is crucial to the design of efficient light emitting devices currently of significant interest due to their potential uses in displays, lasers, and other illumination applications. For example, if the symmetry of an exciton is different from that of the ground state, then the radiative relaxation of the exciton is disallowed and luminescence will be slow and inefficient. Because the ground state is usually anti-symmetric under exchange of spins of electrons comprising the exciton, the decay of a symmetric exciton breaks symmetry. Such excitons are known as triplets, the term reflecting the degeneracy of the state. For every three triplet excitons that are formed by electrical excitation in an OLED, only one symmetric state (or singlet) exciton is created. (<nplcit id="ncit0003" npl-type="s"><text>M.A. Baldo, D. F. O'Brien, M.E. Thompson and S. R. Forrest, Very high-efficiency green organic light-emitting devices based on electrophosphorescence, Applied Physics Letters, 1999, 75, 4-6</text></nplcit>.) Luminescence from a symmetry-disallowed process is known as phosphorescence. Characteristically, phosphorescence may persist for up to several seconds after excitation due to the low probability of the transition. In contrast, fluorescence originates in the rapid decay of a singlet exciton. Since this process occurs between states of like symmetry, it may be very efficient.
Many organic materials exhibit fluorescence from singlet excitons. However, only a very few have been identified which are also capable of efficient room temperature phosphorescence from triplets. Thus, in most fluorescent dyes, the energy contained in the triplet states is wasted. However, if the triplet excited state is perturbed, for example, through spin-orbit coupling (typically introduced by the presence of a heavy metal atom), then efficient phosphoresence is more likely. In this case, the triplet exciton assumes some singlet character and it has a higher probability of radiative decay to the ground state. Indeed, phosphorescent dyes with these properties have demonstrated high efficiency electroluminescence.
Only a few organic materials have been identified which show efficient room temperature phosphorescence from triplets. In contrast, many fluorescent dyes are known (<nplcit id="ncit0004" npl-type="s"><text>C.H. Chen, J. Shi, and C.W. Tang, "Recent developments in molecular organic electroluminescent materials," Macromolecular Symposia, 1997, 125, 1-48</text></nplcit>; <nplcit id="ncit0005" npl-type="s"><text>U. Brackmann, Lambdachrome Laser Dyes (Lambda Physik, Gottingen, 1997</text></nplcit>) and fluorescent efficiencies in solution approaching 100% are not uncommon. (C.H. Chen, 1997, op. cit.) Fluorescence is also not affected by triplet-triplet annihilation, which degrades phosphorescent emission at high excitation densities. (<nplcit id="ncit0006" npl-type="s"><text>M. A. Baldo, et al., "High efficiency phosphorescent emission from organic electroluminescent devices," Nature, 1998, 395, 151-154</text></nplcit>; <nplcit id="ncit0007" npl-type="s"><text>M. A. Baldo, M. E. Thompson, and S.R. Forrest, "An analytic model of triplet-triplet annihilation in electrophosphorescent devices," 1999</text></nplcit>). Consequently, fluorescent materials are suited to many electroluminescent applications, particularly passive matrix displays.
II.B.1.b. Overview of invention relative to basics
The invention relates to the use of a phosphorescent compound having the formula L<sub>2</sub>MX as a phosphorescent emitter in an organic light emitting device, wherein: M is a metal that forms octahedral complexes; L is a monoanionic bidentate ligand, which is bonded to M through an sp<sup>2</sup> hybridized carbon and a heteroatom; X is a monoanionic bidentate ligand; and L and X are inequivalent. These compounds can serve as dopants in a host layer which functions as an emitter layer in organic light emitting diodes.
The compounds used according to this invention can be made by the direct reaction of chloride bridged dimers of the form L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub>, wherein L a bidentate ligand, and M a metal such as Ir, with species XH which serve to introduce a bidentate ligand X. XH can be, for example, acetylacetone, 2-picolinic acid, or N-methylsalicyclanilide, and H stands for hydrogen. The resultant product is of formula L<sub>2</sub>MX, wherein one can have an octahedral disposition of the bidentate ligands L, L, and X about M.
The resultant compounds of formula L<sub>2</sub>MX can be used as phosphorescent emitters in organic light emitting devices. For example, the compound wherein L=(2-phenylbenzothiazole), X=acetylacetonate, and M=Ir (the compound abbreviated as BTIr) when used as a dopant in 4,4'-N,N'-dicarbazole-biphenyl (CBP)(at a level 12% by mass) to form an emitter layer in an OLED shows a quantum efficiency of 12%. For reference, the formula CBP is <chemistry id="chem0001" num="0001"><img file="EP2278637B2_D0001.tif" /></chemistry>
The synthetic process to make L<sub>2</sub>MX may be used advantageously in a situation in which L, by itself, is fluorescent but the resultant L<sub>2</sub>MX is phosphorescent. One specific example of this is where L=coumarin-6.
The synthetic process facilitates the combination of L and X pairs of certain desirable characteristics.
The appropriate selection of L and X allows color tuning of the complex L<sub>2</sub>MX relative to L<sub>3</sub>M. For example, Ir(ppy)<sub>3</sub> and (ppy)<sub>2</sub>Ir(acac) both give strong green emission with a λ<sub>max</sub> of 510 mn [ppy denotes phenyl pyridine]. However, if the X ligand is formed from picolinic acid instead of from acetylacetone, there is a small blue shift of about 15 nm.
Furthermore, X can be selected such that it has a certain HOMO level relative to the L<sub>3</sub>M complex so that carriers (holes or electrons) might be trapped on X (or on L) without a deterioration of emission quality. In this way, carriers (holes or electrons) which might otherwise contribute to deleterious oxidation or reduction of the phosphor would be impeded. The carrier that is remotely trapped could readily recombine with the opposite carrier either intramolecularly or with the carrier from an adjacent molecule.
The invention, and its various embodiments, are discussed in more detail in the examples below. However the embodiments may operate by different mechanisms. Without limitation and without limiting the scope of the invention, we discuss the different mechanisms by which various embodiments of the invention may operate.
II.B.1.c. Dexter and Förster mechanisms
To understand the different embodiments of this invention it is useful to discuss the underlying mechanistic theory of energy transfer. There are two mechanisms commonly discussed for the transfer of energy to an acceptor molecule. In the first mechanism of Dexter transport (<nplcit id="ncit0008" npl-type="s"><text>D.L. Dexter, "A theory of sensitized luminescence in solids," J. Chem. Phys., 1953, 21, 836-850</text></nplcit>), the exciton may hop directly from one molecule to the next. This is a short-range process dependent on the overlap of molecular orbitals of neighboring molecules. It also preserves the symmetry of the donor and acceptor pair (<nplcit id="ncit0009" npl-type="s"><text>E. Wigner and E.W. Wittmer, Uber die Struktur der zweiatomigen Molekelspektren nach der Quantenmechanik, Zeitschrift fur Physik, 1928, 51, 859-886</text></nplcit>; <nplcit id="ncit0010" npl-type="b"><text>M. Klessinger and J. Michl, Excited states and photochemistry of organic molecules (VCH Publishers, New York, 1995</text></nplcit>). Thus, the energy transfer of Eq. (1) is not possible via Dexter mechanism. In the second mechanism of Förster transfer (<nplcit id="ncit0011" npl-type="s"><text>T. Förster, Zwischenmolekulare Energiewanderung and Fluoreszenz, Annalen der Physik, 1948, 2, 55-75</text></nplcit>; <nplcit id="ncit0012" npl-type="b"><text>T. Förster, Fluoreszenz organischer Verbindugen (Vandenhoek and Ruprecht, Gottinghen, 1951</text></nplcit>), the energy transfer of Eq. (1) is possible. In Förster transfer, similar to a transmitter and an antenna, dipoles on the donor and acceptor molecules couple and energy may be transferred. Dipoles are generated from allowed transitions in both donor and acceptor molecules. This typically restricts the Förster mechanism to transfers between singlet states.
Nevertheless, as long as the phosphor can emit light due to some perturbation of the state such as due to spin-orbit coupling introduced by a heavy metal atom, it may participate as the donor in Förster transfer. The efficiency of the process is determined by the luminescent efficiency of the phosphor (<nplcit id="ncit0013" npl-type="b"><text>F Wilkinson, in Advances in Photochemistry (eds. W.A. Noyes, G. Hammond, and J.N. Pitts, pp. 241-268, John Wiley & Sons, New York, 1964</text></nplcit>), i.e. if a radiative transition is more probable than a non-radiative decay, then energy transfer will be efficient. Such triplet-singlet transfers were predicted by Förster (<nplcit id="ncit0014" npl-type="s"><text>T. Förster, "Transfer mechanisms of electronic excitation," Discussions of the Faraday Society, 1959, 27, 7-17</text></nplcit>) and confirmed by Ermolaev and Sveshnikova (<nplcit id="ncit0015" npl-type="s"><text>V.L. Ermolaev and E. B. Sveshnikova, "Inductive-resonance transfer of energy from aromatic molecules in the triplet state," Doklady Akademii Nauk SSSR, 1963, 149, 1295-1298</text></nplcit>), who detected the energy transfer using a range of phosphorescent donors and fluorescent acceptors in rigid media at 77K or 90K. Large transfer distances are observed; for example, with triphenylamine as the donor and chrysoidine as the acceptor, the interaction range is 52Å.
The remaining condition for Förster transfer is that the absorption spectrum should overlap the emission spectrum of the donor assuming the energy levels between the excited and ground state molecular pair are in resonance. In Example 1 of this application, we use the green phosphor fac tris(2-phenylpyridine) iridium (Ir(ppy)<sub>3</sub>; <nplcit id="ncit0016" npl-type="s"><text>M. A. Baldo, et al., Appl. Phys. Lett., 1999, 75, 4-6</text></nplcit>) and the red fluorescent dye [2-methyl-6-[2-(2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl) ethenyl]-4H-pyran-ylidene] propane-dinitrile] ("DCM2"; <nplcit id="ncit0017" npl-type="s"><text>C. W. Tang, S. A. VanSlyke, and C. H. Chen, "Electroluminescence of doped organic films," J. Appl. Phys., 1989, 65, 3610-3616</text></nplcit>). DCM2 absorbs in the green, and, depending on the local polarization field (<nplcit id="ncit0018" npl-type="s"><text>V. Bulovic, et al., "Bright, saturated, red-to-yellow organic light-emitting devices based on polarization-induced spectral shifts," Chem. Phys. Lett., 1998, 287, 455-460</text></nplcit>), it emits at wavelengths between λ=570 nm and λ=650 nm.
It is possible to implement Förster energy transfer from a triplet state by doping a fluorescent guest into a phosphorescent host material. Unfortunately, such systems are affected by competitive energy transfer mechanisms that degrade the overall efficiency. In particular, the close proximity of the host and guest increase the likelihood of Dexter transfer between the host to the guest triplets. Once excitons reach the guest triplet state, they are effectively lost since these fluorescent dyes typically exhibit extremely inefficient phosphorescence.
To maximize the transfer of host triplets to fluorescent dye singlets, it is desirable to maximize Dexter transfer into the triplet state of the phosphor while also minimizing transfer into the triplet state of the fluorescent dye. Since the Dexter mechanism transfers energy between neighboring molecules, reducing the concentration of the fluorescent dye decreases the probability of triplet-triplet transfer to the dye. On the other hand, long range Förster transfer to the singlet state is unaffected. In contrast, transfer into the triplet state of the phosphor is necessary to harness host triplets, and may be improved by increasing the concentration of the phosphor.
II.B.2. Interrelation of device structure and emission
Devices whose structure is based upon the use of layers of organic optoelectronic materials generally rely on a common mechanism leading to optical emission. Typically, this mechanism is based upon the radiative recombination of a trapped charge. Specifically, OLEDs are comprised of at least two thin organic layers separating the anode and cathode of the device. The material of one of these layers is specifically chosen based on the material's ability to transport holes, a "hole transporting layer" (HTL), and the material of the other layer is specifically selected according to its ability to transport electrons, an "electron transporting layer" (ETL). With such a construction, the device can be viewed as a diode with a forward bias when the potential applied to the anode is higher than the potential applied to the cathode. Under these bias conditions, the anode injects holes (positive charge carriers) into the hole transporting layer, while the cathode injects electrons into the electron transporting layer. The portion of the luminescent medium adjacent to the anode thus forms a hole injecting and transporting zone while the portion of the luminescent medium adjacent to the cathode forms an electron injecting and transporting zone. The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, a Frenkel exciton is formed. Recombination of this short-lived state may be visualized as an electron dropping from its conduction potential to a valence band, with relaxation occurring, under certain conditions, preferentially via a photoemissive mechanism. Under this view of the mechanism of operation of typical thin-layer organic devices, the electroluminescent layer comprises a luminescence zone receiving mobile charge carriers (electrons and holes) from each electrode.
As noted above, light emission from OLEDs is typically via fluorescence or phosphorescence. There are issues with the use of phosphorescence. It has been noted that phosphorescent efficiency can decrease rapidly at high current densities. It may be that long phosphorescent lifetimes cause saturation of emissive sites, and triplet-triplet annihilation may also produce efficiency losses. Another difference between fluorescence and phosphorescence is that energy transfer of triplets from a conductive host to a luminescent guest molecule is typically slower than that of singlets; the long range dipole-dipole coupling (Förster transfer) which dominates energy transfer of singlets is (theoretically) forbidden for triplets by the principle of spin symmetry conservation. Thus, for triplets, energy transfer typically occurs by diffusion of excitons to neighboring molecules (Dexter transfer); significant overlap of donor and acceptor excitonic wavefunctions is critical to energy transfer. Another issue is that triplet diffusion lengths are typically long (e.g., >1400Å) compared with typical singlet diffusion lengths of about 200Å. Thus, if phosphorescent devices are to achieve their potential, device structures need to be optimized for triplet properties. In this invention, we exploit the property of long triplet diffusion lengths to improve external quantum efficiency.
Successful utilization of phosphorescence holds enormous promise for organic electroluminescent devices. For example, an advantage of phosphorescence is that all excitons (formed by the recombination of holes and electrons in an EL), which are (in part) triplet-based in phosphorescent devices, may participate in energy transfer and luminescence in certain electroluminescent materials. In contrast, only a small percentage of excitons in fluorescent devices, which are singlet-based, result in fluorescent luminescence.
An alternative is to use phosphorescence processes to improve the efficiency of fluorescence processes.. Fluorescence is in principle 75% less efficient due the three times higher number of symmetric excited states.
II.C. Background of materials
II.C.1. Basic heterostructures
Because one typically has at least one electron transporting layer and at least one hole transporting layer, one has layers of different materials, forming a heterostructure. The materials that produce the electroluminescent emission may be the same materials that function either as the electron transporting layer or as the hole transporting layer. Such devices in which the electron transporting layer or the hole transporting layer also functions as the emissive layer are referred to as having a single heterostructure. Alternatively, the electroluminescent material may be present in a separate emissive layer between the hole transporting layer and the electron transporting layer in what is referred to as a double heterostructure. The separate emissive layer may contain the emissive molecule doped into a host or the emissive layer may consist essentially of the emissive molecule.
That is, in addition to emissive materials that are present as the predominant component in the charge carrier layer, that is, either in the hole transporting layer or in the electron transporting layer, and that function both as the charge carrier material as well as the emissive material, the emissive material may be present in relatively low concentrations as a dopant in the charge carrier layer. Whenever a dopant is present, the predominant material in the charge carrier layer may be referred to as a host compound or as a receiving compound. Materials that are present as host and dopant are selected so as to have a high level of energy transfer from the host to the dopant material. In addition, these materials need to be capable of producing acceptable electrical properties for the OLED. Furthermore, such host and dopant materials are preferably capable of being incorporated into the OLED using materials that can be readily incorporated into the OLED by using convenient fabrication techniques, in particular, by using vacuum-deposition techniques.
II.C.2. Exciton blocking layer
One can have an exciton blocking layer in OLED devices to substantially block the diffusion of excitons, thus substantially keeping the excitons within the emission layer to enhance device efficiency. The material of blocking layer is characterized by an energy difference ("band gap") between its lowest unoccupied molecular orbital (LUMO) and its highest occupied molecular orbital (HOMO) This band gap substantially prevents the diffusion of excitons through the blocking layer, yet has only a minimal effect on the turn-on voltage of a completed electroluminescent device. The band gap is thus preferably greater than the energy level of excitons produced in an emission layer, such that such excitons are not able to exist in the blocking layer. Specifically, the band gap of the blocking layer is at least as great as the difference in energy between the triplet state and the ground state of the host.
For a situation with a blocking layer between a hole-conducting host and the electron transporting layer, one seeks the following characteristics, which are listed in order of relative importance. <ol id="ol0001"><li>1. The difference in energy between the LUMO and HOMO of the blocking layer is greater than the difference in energy between the triplet and ground state singlet of the host material.</li><li>2. Triplets in the host material are not quenched by the blocking layer.</li><li>3. The ionization potential (IP) of the blocking layer is greater than the ionization potential of the host. (Meaning that holes are held in the host.)</li><li>4. The energy level of the LUMO of the blocking layer and the energy level of the LUMO of the host are sufficiently close in energy such that there is less than 50% change in the overall conductivity of the device.</li><li>5. The blocking layer is as thin as possible subject to having a thickness of the layer that is sufficient to effectively block the transport of excitons from the emissive layer into the adjacent layer.</li></ol>
That is, to block excitons and holes, the ionization potential of the blocking layer should be greater than that of the HTL, while the electron affinity of the blocking layer should be approximately equal to that of the ETL to allow for facile transport of electrons.
[For a situation in which the emissive ("emitting") molecule is used without a hole transporting host, the above rules for selection of the blocking layer are modified by replacement of the word "host" by "emitting molecule."]
For the complementary situation with a blocking layer between a electron-conducting host and the hole-transporting layer one seeks characteristics (listed in order of importance): <ol id="ol0002"><li>1. The difference in energy between the LUMO and HOMO of the blocking layer is greater than the difference in energy between the triplet and ground state singlet of the host material.</li><li>2. Triplets in the host material are not quenched by the blocking layer.</li><li>3. The energy of the LUMO of the blocking layer is greater than the energy of the LUMO of the (electron-transporting) host. (Meaning that electrons are held in the host.)</li><li>4. The ionization potential of the blocking layer and the ionization potential of the host are such that holes are readily injected from the blocker into the host and there is less than a 50% change in the overall conductivity of the device.</li><li>5. The blocking layer is as thin as possible subject to having a thickness of the layer that is sufficient to effectively block the transport of excitons from the emissive layer into the adjacent layer.</li></ol>
[For a situation in which the emissive ("emitting") molecule is used without an electron transporting host, the above rules for selection of the blocking layer are modified by replacement of the word "host" by "emitting molecule."]
II.D. Color
As to colors, it is desirable for OLEDs to be fabricated using materials that provide electroluminescent emission in a relatively narrow band centered near selected spectral regions, which correspond to one of the three primary colors, red, green and blue so that they may be used as a colored layer in an OLED or SOLED. It is also desirable that such compounds be capable of being readily deposited as a thin layer using vacuum deposition techniques so that they may be readily incorporated into an OLED that is prepared entirely from vacuum-deposited organic materials.
<patcit id="pcit0005" dnum="US77433396" dnum-type="L"><text>U.S. 08/774,333, filed December 23, 1996</text></patcit> (allowed), is directed to OLEDs containing emitting compounds that produce a saturated red emission.
<u>III. SUMMARY OF THE INVENTION</u>
The invention is directed to the use of a phosphorescent compound having the formula L<sub>2</sub>MX as a phosphorescent emitter in an organic light emitting device, wherein: M is a metal that forms octahedral complexes; L is a monoanionic bidentate ligand, which is bonded to M through an sp<sup>2</sup> hybridized carbon and a heteroatom; X is a monoanionic bidentate ligand; and L and X are inequivalent.
Furthermore, the present invention is directed to the use of complexes of transition metal species M with bidentate ligands L and M in compounds of formula L<sub>2</sub>MX in the emitter layer of organic light emitting diodes. A preferred embodiment is compounds of formula L<sub>2</sub>IrX, wherein L and X are distinct bidentate ligands, as dopants in a host layer comprising to function as a emitter layer in organic light emitting diodes.
The present document also describes an improved synthesis of organometallic molecules which function as emitters in light emitting devices. The compounds of this invention can be made according to the reaction L<sub>2</sub>M(µ-C1)<sub>2</sub>ML<sub>2</sub> + XH -> L<sub>2</sub>MX + HCl wherein L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> is a chloride bridged dimer with L a bidentate ligand, and M a metal such as Ir; XH is a Bronsted acid which reacts with bridging chloride and serves to introduce a bidentate ligand X, where XH can be, for example, acetylacetone, 2-picolinic acid, or N-methylsalicyclanilide. The method involves combining the L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> chloride bridged dimer with the XH entity. L<sub>2</sub>MX has approximate octahedral disposition of the bidentate ligands L, L, and X about M.
The present invention is further directed to the use of compounds of formula L<sub>2</sub>MX as phosphorescent emitters in organic light emitting devices. For example, the compound wherein L=(2-phenylbenzothiazole), X=acetylacetonate, and M=Ir (abbreviated as BTIr) when used as a dopant in CBP (at a level 12% by mass) to form an emitter layer in an OLED shows a quantum efficiency of 12%. For reference, the formula of 4,4'-N,N'-dicarbazole-biphenyl (CBP) is <chemistry id="chem0002" num="0002"><img file="EP2278637B2_D0002.tif" /></chemistry>
The present invention is further directed to the use of the organometallic complex L<sub>2</sub>MX wherein L, by itself, is fluorescent but the resultant L<sub>2</sub>MX is phosphorescent. One specific example of this is where L=coumarin-6.
The present invention is further directed to the appropriate selection of L and X to allow color tuning of the complex L<sub>2</sub>MX relative to L<sub>3</sub>M. For example, Ir(ppy)<sub>3</sub> and (ppy)<sub>2</sub>Ir(acac) both give strong green emission with a λ<sub>max</sub> of 510 nm [ppy denotes phenyl pyridine]. However, if the X ligand is formed from picolinic acid instead of from acetylacetone, there is a small blue shift of about 15 nm.
The present invention is further directed to a selection of X such that it has a certain HOMO level relative to the L<sub>3</sub>M complex so that carriers (holes or electrons) might be trapped on X (or on L) without a deterioration of emission quality. In this way, carriers (holes or electrons) which might otherwise contribute to deleterious oxidation (or reduction) of the phosphor would be impeded. The carrier that is remotely trapped could readily recombine with the opposite carrier either intramolecularly or with the carrier from an adjacent molecule.
<u>XV. BRIEF DESCRIPTION OF THE DRAWINGS</u>
<ul id="ul0001" list-style="none" compact="compact"><li><figref idref="f0001">Figure 1</figref>. Expected structure of L<sub>2</sub>IrX complexes along with the structure expected for <b>PPIr</b>. Four examples of X ligands used for these complexes are also shown. The structure shown is for an acac derivative. For the other X type ligands the O-O ligand would be replaced with an N-O ligand.</li><li><figref idref="f0002">Figure 2</figref>. Comparison of facial and meridianal isomers of L<sub>3</sub>M.</li><li><figref idref="f0002">Figure 3</figref>. Molecular formulae of mer isomers disclosed herewith: mer-Ir(ppy)<sub>3</sub> and mer-Ir(bq)3. PPY (or ppy) denotes phenyl pyridyl and BQ (or bq) denotes 7,8-benzoquinoline.</li><li><figref idref="f0003">Figure 4</figref>. Models of mer-Ir(ppy)<sub>3</sub> and (ppy)<sub>2</sub>Ir(acac).</li><li><figref idref="f0004 f0005">Figure 5</figref>. (a) Electroluminescent device data (quantum efficiency vs. current density) for 12% by mass "BTIr" in CBP. BTIr stands for bis (2-phenylbenzothiazole) iridium acetylacetonate. (b) emission spectrum from device</li><li><figref idref="f0006">Figure 6</figref>. Representative molecule to trap holes.</li><li><figref idref="f0007">Figure 7</figref>. Emission spectrum of Ir(3-MeOppy)<sub>3</sub>.</li><li><figref idref="f0008">Figure 8</figref>. Emission spectrum of tpyIrsd.</li><li><figref idref="f0009">Figure 9</figref>. Proton NMR spectrum of tpyIrsd (=typIrsd).</li><li><figref idref="f0010">Figure 10</figref>. Emission spectrum of thpyIrsd.</li><li><figref idref="f0011">Figure 11</figref>. Proton NMR spectrum of thpyrIrsd.</li><li><figref idref="f0012">Figure 12</figref>. Emission spectrum of btIrsd.</li><li><figref idref="f0013">Figure 13</figref>. Proton NMR spectrum of btIrsd.</li><li><figref idref="f0014">Figure 14</figref>. Emission spectrum of BQIr.</li><li><figref idref="f0015">Figure 15</figref>. Proton NMR of BQIr.</li><li><figref idref="f0016">Figure 16</figref>. Emission spectrum of BQIrFA.</li><li><figref idref="f0017">Figure 17</figref>. Emission spectrumof THIr (=thpy; THPIr).</li><li><figref idref="f0018">Figure 18</figref>. Proton NMR spectrum of THPIr.</li><li><figref idref="f0019">Figure 19</figref>. Emission spectra of PPIr.</li><li><figref idref="f0020">Figure 20</figref>. Proton NMR spectrum of PPIr.</li><li><figref idref="f0021">Figure 21</figref>. Emission spectrum of BTHPIr (=BTPIr)</li><li><figref idref="f0022">Figure 22</figref>. Emission spectrum of tpylr.</li><li><figref idref="f0023">Figure 23</figref>. Crystal structure of tpyIr showing trans arrangement of nitrogen.</li><li><figref idref="f0024">Figure 24</figref>. Emission spectrum of C6.</li><li><figref idref="f0025">Figure 25</figref>. Emission spectrum of C6Ir.</li><li><figref idref="f0026">Figure 26</figref>. Emission spectrum of PZIrP.</li><li><figref idref="f0027">Figure 27</figref>. Emission spectrum of BONIr.</li><li><figref idref="f0028">Figure 28</figref>. Proton NMR of BONIr.</li><li><figref idref="f0029">Figure 29</figref>. Emission spectrum of BTIr.</li><li><figref idref="f0030">Figure 30</figref>. Proton NMR of BTIr.</li><li><figref idref="f0031">Figure 31</figref>. Emission spectrum of BOIr.</li><li><figref idref="f0032">Figure 32</figref>. Proton NMR of BOIr.</li><li><figref idref="f0033">Figure 33</figref>. Emission spectrum of BTIrQ.</li><li><figref idref="f0034">Figure 34</figref>. Proton NMR spectrum of BTIrQ.</li><li><figref idref="f0035">Figure 35</figref>. Emission spectrum of BTIrP.</li><li><figref idref="f0036">Figure 36</figref>. Emission spectrum of BOIrP.</li><li><figref idref="f0037">Figure 37</figref>. Emission of btIr type complexes with different ligands.</li><li><figref idref="f0038">Figure 38</figref>. Proton NMR of mer-Irbq.</li><li><figref idref="f0039">Figure 39</figref>. Other suitable L and X ligands for L2MX compounds.</li><li><figref idref="f0040">Figure 40</figref>. Examples of L L' L" M compounds.</li></ul>
<u>V. DETAILED DESCRIPTION OF THE INVENTION</u>
V.A. Chemistry
The invention relates to the use of a phosphorescent compound having the formula L<sub>2</sub>MX as a phosphorescent emitter in an organic light emitting device, wherein: M is a metal that forms octahedral complexes; L is a monoanionic bidentate ligand, which is bonded to M through an sp<sup>2</sup> hybridized carbon and a heteroatom; X is a monoanionic bidentate ligand; and L and X are inequivalent. This document also describes the synthesis and use of certain organometallic molecules of formula L<sub>2</sub>MX which may be doped into a host phase in an emitter layer of an organic light emitting diode. Optionally, the molecules of formula L<sub>2</sub>MX may be used at elevated concentrations or neat in the emitter layer.
V.A.1. Dopants
The general chemical formula for the molecules which are doped into the host phase is L<sub>2</sub>MX, wherein M is a transition metal ion which forms octahedral complexes, L is a bidentate ligand, and X is a distinct bidentate ligand.
Examples of L are 2-(1-naphthyl)benzoxazole), (2-phenylbenzoxazole), (2-phenylbenzothiazole), (7,8-benzoquinoline), coumarin, thienylpyridine, phenylpyridine, benzothienylpyridine, 3-methoxy-2-phenylpyridine, and tolylpyridine.
Examples of X are acetylacetonate ("acac"), hexafluoroacetylacetonate, salicylidene, picolinate, and 8-hydroxyquinolinate.
Further examples of L and X are given in <figref idref="f0039">Figure 39</figref> and still further examples of L and X may be found in <nplcit id="ncit0019" npl-type="b"><text>Comprehensive Coordination Chemistry, Volume 2, G. Wilkinson (editor-in-chief), Pergamon Press, especially in chapter 20.1 (beginning at page 715) by M. Calligaris and L. Randaccio</text></nplcit> and in chapter 20.4 (beginning at page 793) by R. S. Vagg.
V.A.2. Synthesis of molecules of formula L
2
MX
V.A.2.a. Reaction scheme
The compounds of formula L<sub>2</sub>MX can be made according to the reaction L<sub>2</sub>M(µ.-Cl)<sub>2</sub>ML<sub>2</sub> + XH -> L<sub>2</sub>MX + HCl wherein L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> is a chloride bridged dimer with L a bidentate ligand, and M a metal such as Ir; XH is a Bronsted acid which reacts with bridging chloride and serves to introduce a bidentate ligand X, where XH can be, for example, acetylacetone, hexafluoroacetylacetone, 2-picolinic acid, or N-methylsalicyclanilide. L<sub>2</sub>MX has approximate octahedral disposition of the bidentate ligands L, L, and X about M.
V.A.2.b. Examples
L<sub>2</sub>Ir(µ-Cl)<sub>2</sub>IrL<sub>2</sub> complexes were prepared from IrCl<sub>3</sub>nH<sub>2</sub>O and the appropriate ligand by literature procedures (<nplcit id="ncit0020" npl-type="s"><text>S. Sprouse, K. A. King, P. J. Spellane, R. J. Watts, J. Am. Chem. Soc., 1984, 106, 6647-6653</text></nplcit>; for general reference: <nplcit id="ncit0021" npl-type="s"><text>G. A. Carlson, et al., Inorg. Chem., 1993, 32, 4483</text></nplcit>; <nplcit id="ncit0022" npl-type="s"><text>B. Schmid, et al., Inorg. Chem., 1993, 33, 9</text></nplcit>; <nplcit id="ncit0023" npl-type="s"><text>F. Garces, et al.; Inorg. Chem.., 1988, 27, 3464</text></nplcit>; <nplcit id="ncit0024" npl-type="s"><text>M. G. Colombo, et al., Inorg. Chem., 1993, 32, 3088</text></nplcit>; <nplcit id="ncit0025" npl-type="s"><text>A. Mamo, et al., Inorg. Chem., 1997, 36, 5947</text></nplcit>; <nplcit id="ncit0026" npl-type="s"><text>S. Serroni, et al.; J. Am. Chem. Soc., 1994, 116, 9086</text></nplcit>; <nplcit id="ncit0027" npl-type="s"><text>A. P. Wilde, et al., J. Phys. Chem., 1991, 95, 629</text></nplcit>; <nplcit id="ncit0028" npl-type="s"><text>J. H. van Diemen, et al., Inorg. Chem., 1992, 31, 3518</text></nplcit>; <nplcit id="ncit0029" npl-type="s"><text>M. G. Colombo, et al., Inorg. Chem., 1994, 33, 545</text></nplcit>)
<b>Ir(3-MeOppy)<sub>3</sub>.</b> Ir(acac)<sub>3</sub> (0.57 g, 1.17 mmol) and 3-methoxy-2-phenylpyridine (1.3 g, 7.02 mmol) were mixed in 30 ml of glycerol and heated to 200°C for 24 hrs under N<sub>2</sub>. The resulting mixture was added to 100 ml of 1 M HCl. The precipitate was collected by filtration and purified by column chromatography using CH<sub>2</sub>Cl<sub>2</sub> as the eluent to yield the product as bright yellow solids (0.35 g, 40%). MS (EI): m/z (relative intensity) 745 (M<sup>+</sup>, 100), 561 (30), 372 (35). Emission spectrum in <figref idref="f0007">Figure 7</figref>.
<b>tpyIrsd.</b> The chloride bridge dimer (tpyIrCl)<sub>2</sub> (0.07 g, 0.06 mmol), salicylidene (0.022 g, 0.16 mmol) and Na<sub>2</sub>CO<sub>3</sub> (0.02 g, 0.09 mmol) were mixed in 10 ml of 1,2-dichloroethane and 2 ml of ethanol. The mixture was refluxed under N<sub>2</sub> for 6 hrs or until no dimer was revealed by TLC. The reaction was then cooled and the solvent evaporated. The excess salicylidene was removed by gentle heating under vacuum. The residual solid was redissolved in CH<sub>2</sub>Cl<sub>2</sub> and the insoluble inorganic materials were removed by filtration. The filtrate was concentrated and column chromatographed using CH2Cl2 as the eluent to yield the product as bright yellow solids (0.07 g, 85%). MS (EI): m/z (relative intensity) 663 (M<sup>+</sup>, 75), 529 (100), 332 (35). The emission spectrum is in <figref idref="f0008">Figure 8</figref> and the proton NMR spectrum is in <figref idref="f0009">Figure 9</figref>.
<b>thpyIrsd.</b> The chloride bridge dimer (thpyIrCl)<sub>2</sub> (0.21 g, 0.19 mmol) was treated the same way as (tpyIrCl)<sub>2</sub>. Yield: 0.21 g, 84%. MS (EI): m/z (relative intensity) 647 (M<sup>+</sup>, 100), 513 (30), 486 (15), 434 (20), 324 (25). The emission spectrum is in <figref idref="f0010">Figure 10</figref> and the proton NMR spectrum is in <figref idref="f0011">Figure 11</figref>.
<b>btIrsd.</b> The chloride bridge dimer (btIrCl)<sub>2</sub> (0.05 g, 0.039 mmol) was treated the same way as (tpyIrCl)<sub>2</sub>. Yield: 0.05 g, 86%. MS (EI): m/z (relative intensity) 747 (M<sup>+</sup>, 100), 613 (100), 476 (30), 374 (25), 286 (32). The emission spectrum is in <figref idref="f0012">Figure 12</figref> and the proton NMR spectrum is in <figref idref="f0013">Figure 13</figref>.
<b>Ir(bq)<sub>2</sub>(acac), BQIr.</b> The chloride bridged dimer (Ir(bq)<sub>2</sub>Cl)<sub>2</sub> (0.091 g, 0.078 mmol), acetylacetone (0.021 g) and sodium carbonate (0.083 g) were mixed in 10 ml of 2-ethoxyethanol. The mixture was refluxed under N<sub>2</sub> for 10 hrs or until no dimer was revealed by TLC. The reaction was then cooled and the yellow precipitate filtered. The product was purified by flash chromatography using dichloromethane. Product: bright yellow solids (yield 91%). <sup>1</sup>H NMR (360 MHz, acetone-d<sub>6</sub>), ppm: 8.93 (d,2H), 8.47 (d,2H), 7.78 (m,4H), 7.25 (d,2H), 7.15 (d,2H), 6.87 (d,2H), 6.21 (d,2H), 5.70 (s,1H), 1.63 (s,6H). MS, e/z: 648 (M+,80%), 549 (100%). The emission spectrum is in <figref idref="f0014">Figure 14</figref> and the proton NMR spectrum is in <figref idref="f0015">Figure 15</figref>.
<b>Ir(bq)<sub>2</sub>(Facac), BQIrFA.</b> The chloride bridged dimer (Ir(bq)<sub>2</sub>Cl)<sub>2</sub> (0.091 g, 0.078 mmol), hexafluoroacetylacetone (0.025 g) and sodium carbonate (0.083 g) were mixed in 10 ml of 2-ethoxyethanol. The mixture was refluxed under N<sub>2</sub> for 10 hrs or until no dimer was revealed by TLC. The reaction was then cooled and the yellow precipitate filtered. The product was purified by flash chromatography using dichloromethane. Product: yellow solids (yield 69%). <sup>1</sup>H NMR (360 MHz, acetone-d<sub>6</sub>), ppm: 8.99 (d,2H), 8.55 (d,2H), 7.86 (m,4H), 7.30 (d,2H), 7.14 (d,2H), 6.97 (d,2H), 6.13 (d,2H), 5.75 (s,1H). MS, e/z: 684 (M+,59%), 549 (100%). Emission spectrum in <figref idref="f0016">Figure 16</figref>.
<b>Ir(thpy)<sub>2</sub>(acac), THPIr.</b> The chloride bridged dimer (Ir(thpy)<sub>2</sub>Cl)<sub>2</sub> (0.082 g, 0.078 mmol), acetylacetone (0.025 g) and sodium carbonate (0.083 g) were mixed in 10 ml of 2-ethoxyethanol. The mixture was refluxed under N<sub>2</sub> for 10 hrs or until no dimer was revealed by TLC. The reaction was then cooled and the yellow precipitate filtered. The product was purified by flash chromatography using dichloromethane. Product: yellow-orange solid (yield 80%). <sup>1</sup>H NMR (360 MHz, acetone-d<sub>6</sub>), ppm: 8.34 (d,2H), 7.79 (m,2H), 7.58 (d,2H), 7.21 (d,2H), 7.15 (d,2H), 6.07 (d,2H), 5.28 (s,1H, 1.70 (s,6H). MS, e/z: 612 (M+,89%), 513 (100%). The emission spectrum is in <figref idref="f0017">Figure 17</figref> (noted "THIr") and the proton NMR spectrum is in <figref idref="f0018">Figure 18</figref>.
<b>Ir(ppy)<sub>2</sub>(acac), PPIr</b>. The chloride bridged dimer (Ir(ppy)<sub>2</sub>Cl)<sub>2</sub> (0.080 g, 0.078 mmol), acetylacetone (0.025 g) and sodium carbonate (0.083 g) were mixed in 10 ml of 2-ethoxyethanol. The mixture was refluxed under N<sub>2</sub> for 10 hrs or until no dimer was revealed by TLC. The reaction was then cooled and the yellow precipitate filtered. The product was purified by flash chromatography using dichloromethane. Product: yellow solid (yield 87%). <sup>1</sup>H NMR (360 MHz, acetone-d<sub>6</sub>), ppm: 8.54 (d,2H), 8.06 (d,2H), 7.92 (m,2H), 7.81 (d,2H), 7.35 (d,2H), 6.78 (m,2H), 6.69 (m,2H), 6.20 (d,2H), 5.12 (s,1H, 1.62 (s,6H). MS, e/z: 600 (M+,75%), 501 (100%). The emission spectrum is in <figref idref="f0019">Figure 19</figref> and the proton NMR spectrum is in <figref idref="f0020">Figure 20</figref>.
<b>Ir(bthpy)<sub>2</sub>(acac), BTPIr.</b> The chloride bridged dimer (Ir(bthpy)<sub>2</sub>Cl)<sub>2</sub> (0.103 g, 0.078 mmol), acetylacetone (0.025 g) and sodium carbonate (0.083 g) were mixed in 10 ml of 2-ethoxyethanol. The mixture was refluxed under N<sub>2</sub> for 10 hrs or until no dimer was revealed by TLC. The reaction was then cooled and the yellow precipitate filtered. The product was purified by flash chromatography using dichloromethane. Product: yellow solid (yield 49%). MS, e/z: 712 (M+,66%), 613 (100%). Emission spectrum is in <figref idref="f0021">Figure 21</figref>.
<b>[Ir(ptpy)<sub>2</sub>Cl]<sub>2</sub>:</b> A solution of IrCl<sub>3</sub>·xH<sub>2</sub>O (1.506g , 5.030 mmol) and 2-(p-tolyl)pyridine (3.509 g, 20.74 mmol) in 2-ethoxyethanol (30 mL) was refluxed for 25 hours. The yellow-green mixture was cooled to room temperature and 20 mL of 1.0 M HCl was added to precipitate the product. The mixture was filtered and washed with 100 mL of 1.0 M HCl followed by 50 mL of methanol then dried. The product was obtained as a yellow powder (1.850 g, 65%).
<b>[Ir(ppz)<sub>2</sub>Cl]<sub>2</sub>:</b> A solution of IrCl<sub>3</sub>·xH<sub>2</sub>O (0.904 g , 3.027 mmol) and 1-phenylpyrazole (1.725 g, 11.96 mmol) in 2-ethoxyethanol (30 mL) was refluxed for 21 hours. The gray-green mixture was cooled to room temperature and 20 mL of 1.0 M HCl was added to precipitate the product. The mixture was filtered and washed with 100 mL of 1.0 M HCl followed by 50 mL of methanol then dried. The product was obtained as a light gray powder (1.133 g, 73%).
<b>[Ir(C6)<sub>2</sub>Cl]<sub>2</sub>:</b> A solution of IrCl<sub>3</sub>·xH<sub>2</sub>O (0.075 g, 0.251 mmol) and coumarin C6 [3-(2-benzothiazolyl)-7-(diethyl)coumarin] (Aldrich) (0.350 g, 1.00 mmol) in 2-ethoxyethanol (15 mL) was refluxed for 22 hours. The dark red mixture was cooled to room temperature and 20 mL of 1.0 M HCl was added to precipitate the product. The mixture was filtered and washed with 100 mL of 1.0 M HCl followed by 50 mL of methanol. The product was dissolved in and precipitated with methanol. The solid was filtered and washed with methanol until no green emission was observed in the filtrate. The product was obtained as an orange powder (0.0657 g, 28%).
<b>Ir(ptpy)<sub>2</sub>acac (tpyIr):</b> A solution of [Ir(ptpy)<sub>2</sub>Cl]<sub>2</sub> (1.705 g, 1.511 mmol), 2,4-pentanedione (3.013g, 30.08 mmol) and (1.802 g,, 17.04 mmol) in 1,2-dichloroethane (60 mL) was refluxed for 40 hours. The yellow-green mixture was cooled to room temperature and the solvent was removed under reduced pressure. The product was taken up in 50 mL of CH<sub>2</sub>Cl<sub>2</sub> and filtered through Celite. The solvent was removed under reduced pressure to yield orange crystals of the product (1.696 g, 89%). The emission spectrum is given in <figref idref="f0022">Figure 22</figref>. The results of an x-ray diffraction study of the structure are given in <figref idref="f0023">Figure 23</figref>. One sees that the nitrogen atoms of the tpy ("tolyl pyridyl") groups are in a trans configuration. For the x-ray study, the number of reflections was 4663 and the R factor was 5.4%.
<b>Ir(C6)<sub>2</sub>acac (C6Ir):</b> Two drops of 2,4-pentanedione and an excess of Na<sub>2</sub>CO<sub>3</sub> was added to solution of [Ir(C6)<sub>2</sub>Cl]<sub>2</sub> in CDCl<sub>3</sub>. The tube was heated for 48 hours at 50 °C and then filtered through a short plug of Celite in a Pasteur pipet. The solvent and excess 2,4-pentanedione were removed under reduced pressure to yield the product as an orange solid. Emission of C6 in <figref idref="f0024">Figure 24</figref> and of C6lr in <figref idref="f0025">Figure 25</figref>.
<b>Ir(ppz)<sub>2</sub>picolinate (PZIrp):</b> A solution of [Ir(ppz)<sub>2</sub>Cl)<sub>2</sub> (0.0545 g, 0.0530 mmol) and picolinic acid (0.0525 g, 0.426 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was refluxed for 16 hours. The light green mixture was cooled to room temperature and the solvent was removed under reduced pressure. The resultant solid was taken up in 10 mL of methanol and a light green solid precipitated from the solution. The supernatant liquid was decanted off and the solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and filtered through a short plug of silica. The solvent was removed under reduced pressure to yield light green crystals of the product (0.0075 g, 12%). Emission in <figref idref="f0026">Figure 26</figref>.
<b>2-(1-naphthyl)benzoxazole, (BZO-Naph).</b> (11.06g, 101 mmol) of 2-aminophenol was mixed with (15.867g, 92.2mmol) of 1-naphthoic acid in the presence of polyphosphoric acid. The mixture was heated and stirred at 240°C under N<sub>2</sub> for 8 hrs. The mixture was allowed to cool to 100°C, this was followed by addition of water. The insoluble residue was collected by filtration, washed with water then reslurried in an excess of 10 % Na2CO3. The alkaline slurry was filtered and the product washed thoroughly with water and dried under vacuum. The product was purified by vacuum distillation. BP 140°C /0.3 mmHg. Yield 4.8 g (21%).
<b>Tetrakis(2-(1-naphthyl)benzoxazole<i>C</i><sup>2</sup>,<i>N'</i>)(µ-dichloro)diiridium. ((Ir<sub>2</sub>(BZO-Naph)<sub>4</sub>Cl)<sub>2</sub>).</b> Iridium trichloride hydrate (0.388 g) was combined with 2-(1-naphthyl)benzoxazole (1.2 g, 4.88 mmol), The mixture was dissolved in 2-ethoxyethanol (30 mL) then refluxed for 24 hrs. The solution was cooled to room temperature, the resulting orange solid product was collected in a centrifuge tube. The dimer was washed with methanol followed by chloroform through four cycles of centrifuge/redispersion cycles. Yield 0.66g
<b>Bis(2-(1-naphthyl)benzoxazole) acetylacetonate, Ir(BZO-Naph)<sub>2</sub>(acac), (BONIr).</b> The chloride bridged dimer (Ir<sub>2</sub>(BZO-Naph)<sub>4</sub>Cl)<sub>2</sub> (0.66 g, 0.46 mmol), acetylacetone (0.185 g) and sodium carbonate (0.2 g) were mixed in 20 ml of dichloroethane. The mixture was refluxed under N<sub>2</sub> for 60 hrs. The reaction was then cooled and the orange/red precipitate was collected in centrifuge tube. The product was washed with water/methanol (1:1) mixture followed by methanol wash through four cycles of centrifuge/redispersion cycles. The orange/red solid product was purified by sublimation. SP 250°C/ 2x10<sup>-5</sup> torr.yield 0.57g (80%). The emission spectrum is in <figref idref="f0027">Figure 27</figref> and the proton NMR spectrum is in <figref idref="f0028">Figure 28</figref>.
<b>Bis(2-phenylbenzothiazole) Iridium acetylacetonate (BTIr):</b> 9.8 mmol (0.98g. 1.0mL) of 2,4-pentanedione was added to a room-temperature solution of 2.1 mmol 2-phenylbenzothiazole Iridium chloride dimer (2.7g) in 120mL of 2-ethoxyethanol. Approximately 1g of sodium carbonate was added, and the mixture was heated to reflux under nitrogen in an oil bath for several hours. Reaction mixture was cooled to room temperature, and the orange precipitate was filtered off via vacuum. The filtrate was concentrated and methanol was added to precipitate more product. Successive filtrations and precipitations afforded a 75%yield. The emission spectrum is in <figref idref="f0029">Figure 29</figref> and the proton NMR spectrum is in <figref idref="f0030">Figure 30</figref>. <b>Bis(2-phenylbenzooxazole) Iridium acac (BOIr):</b> 9.8 mmol (0.98g, 1.0mL) of 2,4-pentanedione was added to a room-temperature solution of 2.4 mmol 2-phenylbenzoxazole Iridium chloride dimer (3.0g) in 120mL of 2-ethoxyethanol. Approximately 1g of sodium carbonate was added, and the mixture was heated to reflux under nitrogen in an oil bath overnight (∼16hrs.). Reaction mixture was cooled to room temperature, and the yellow precipitate was filtered off via vacuum. The filtrate was concentrated and methanol was added to precipitate more product. Successive filtrations and precipitations afforded a 60%yield. The emission spectrum is in <figref idref="f0031">Figure 31</figref> and the proton NMR spectrum is in <figref idref="f0032">Figure 32</figref>.
<b>Bis(2-phenylbenzothiazole) Iridium (8-hydroxyquinolate) (BTIrQ):</b> 4.7 mmol (0.68g) of 8-hydroxyquinoline was added to a room-temperature solution of 0.14 mmol 2-phenylbenzothiazole Iridium chloride dimer (0.19g) in 20mL of 2-ethoxyethanol. Approximately 700mg of sodium carbonate was added, and the mixture was heated to reflux under nitrogen in an oil bath overnight (23hrs.). Reaction mixture was cooled to room temperature, and the red precipitate was filtered off via vacuum. The filtrate was concentrated and methanol was added to precipitate more product. Successive filtrations and precipitations afforded a 57%yield. The emission spectrum is in <figref idref="f0033">Figure 33</figref> and the proton NMR spectrum is in <figref idref="f0034">Figure 34</figref>.
<b>Bis(2-phenylbenzothiazole) Iridium picolinate (BTIrP):</b> 2.14 mmol (0.26g) of picolinic acid was added to a room-temperature solution of 0.80 mmol 2-phenylbenzothiazole Iridium chloride dimer (1.0g) in 60mL of dichloromethane. The mixture was heated to reflux under nitrogen in an oil bath for 8.5 hours. The reaction mixture was cooled to room temperature, and the yellow precipitate was filtered off via vacuum. The filtrate was concentrated and methanol was added to precipitate more product. Successive filtrations and precipitations yielded about 900mg of impure product. Emission spectrum is in <figref idref="f0035">Figure 35</figref>. <b>Bis(2-phenylbenzooxazole) Iridium picolinate (BOIrP):</b> 0.52 mmol (0.064g) of picolinic acid was added to a room-temperature solution of 0.14 mmol 2-phenylbenzoxazole Iridium chloride dimer (0.18g) in 20mL of dichloromethane. The mixture was heated to reflux under nitrogen in an oil bath overnight (17.5hrs.). Reaction mixture was cooled to room temperature, and the yellow precipitate was filtered off via vacuum. The precipitate was dissolved in dichloromethane and transferred to a vial, and the solvent was removed. Emission spectrum is in <figref idref="f0036">Figure 36</figref>. Comparative emission spectra for different L' in btlr complexes are in <figref idref="f0037">Figure 37</figref>.
V.A.2.c. Advantages over the prior art
This synthesis has certain advantages over the prior art. Compounds of formula PtL<sub>3</sub> cannot be sublimed without decomposition. Obtaining compounds of formula IrL<sub>3</sub> can be problematic. Some ligands react cleanly with Ir(acac)3 to give the tris complex, but more than half of the ligands we have studied do not react cleanly in the reaction: 3 L + Ir(acac)<sub>3</sub> -> L<sub>3</sub>Ir + acacH typically 30% yield, L=2-phenylpyridine, benzoquinoline, 2-thienylpyridine A preferred route to Ir complexes can be through the chloride-bridged dimer L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> via 4 L + IrCl3.hH20 -> L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> + 4 Hcl Although fewer than 10% of the ligands we have studied failed to give the Ir dimer cleanly and in high yield, the conversion of the dimer into the tris complex IrL<sub>3</sub> is problematic working for only a few ligands. L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> + 2Ag<sup>+</sup> + 2L -> L<sub>3</sub>Ir + 2AgCl
We have discovered that a far more fruitful approach to preparing phosphorescent complexes is to use chloride bridged dimers to create emitters. The dimer itself does not emit strongly, presumably because of strong self quenching by the adjacent metal (e.g., iridium) atoms. We have found that the chloride ligands can be replaced by a chelating ligand to give a stable, octahedral metal complex through the chemistry: L<sub>2</sub>M(µ-Cl)<sub>2</sub>ML<sub>2</sub> + XH -> L<sub>2</sub>MX + HCl
We have extensively studied the system wherein M = iridium. The resultant iridium complexes emit strongly, in most cases with lifetimes of 1-3 microseconds ("µsec"). Such a lifetime is indicative of phosphorescence (see Charles Kittel, Introduction to Solid State Physics). The transition in these materials is a metal ligand charge transfer ("MLCT").
In the Detailed Discussion below, we analyze data of emission spectra and lifetimes of a number of different complexes, all of which can be characterized as L<sub>2</sub>MX (M=Ir), where L is a cyclometallated (bidentate) ligand and X is a bidentate ligand. In nearly every case, the emission in these complexes is based on an MLCT transition between Ir and the L ligand or a mixture of that transition and an intraligand transition. Specific examples are described below. Based on theoretical and spectroscopic studies, the complexes have an octahedral coordination about the metal (for example, for the nitrogen heterocycles of the L ligand, there is a trans disposition in the Ir octahedron).
Specifically, in <figref idref="f0001">Figure 1</figref>, we give the structure for L<sub>2</sub>IrX. wherein L = 2-phenyl pyridine and X = acac, picolinate (from picolinic acid), salicylanilide, or 8-hydroxyquinolinate.
V.A.2.d. Facial vs. meridianal isomers
A slight variation of the synthetic route to make L<sub>2</sub>IrX allows formation of meridianal isomers of formula L<sub>3</sub>Ir. The L<sub>3</sub>Ir complexes that have been disclosed previously all have a facial disposition of the chelating ligands. Herewith, we disclose the formation and use of meridianal L<sub>3</sub>Ir complexes as phosphors in OLEDs. The two structures are shown in the <figref idref="f0002">Figure 2</figref>.
The facial L<sub>3</sub>Ir isomers have been prepared by the reaction of L with Ir(acac)<sub>3</sub> in refluxing glycerol as described in equation 1 (below). A preferred route into L<sub>3</sub>Ir complexes is through the chloride bridged dimer (L<sub>2</sub>Ir(µ-Cl)<sub>2</sub>IrL<sub>2</sub>), equation 2+3 (below). The product of equation 3 is a facial isomer, identical to the one formed from Ir(acac)<sub>3</sub>, The benefit of the latter prep is a better yield of facial-L<sub>3</sub>Ir. If the third ligand is added to the dimer in the presence of base and acetylacetone (no Ag<sup>+</sup>) a good yield of the meridianal isomer is obtained. The meridianal isomer does not convert to the facial one on recrystallization, refluxing in coordinating solvents or on sublimation. Two examples of these meridianal complexes have been formed, mer-Irppy and mer-Irbq (<figref idref="f0002">Figure 3</figref>), however, we believe that any ligand that gives a stable facial-L<sub>3</sub>Ir can be made into a meridianal form as well. (1) 3 L + Ir(acac)<sub>3</sub> → facial- L<sub>3</sub>Ir + acacH typically 30% yield, L = 2-phenylpyridine, bezoquinoline, 2-thienylpyridine (2) 4 L + IrCl<sub>3</sub>nH<sub>2</sub>O → L<sub>2</sub>Ir(µ-Cl)<sub>2</sub>IrL<sub>2</sub> + 4 HCl typically > 90% yield, see attached spectra for examples of L, also works well for all ligands that work in (1) (3) L<sub>2</sub>Ir(µ-Cl)<sub>2</sub>IrL<sub>2</sub> + 2 Ag<sup>+</sup> + 2 L → 2 facial-L<sub>3</sub>Ir + 2 AgCl typically 30% yield, only works well for the same ligands that work well for (1) (4) L<sub>2</sub>Ir(µ-Cl)<sub>2</sub>IrL<sub>2</sub> + XH + Na<sub>2</sub>CO<sub>3</sub> + L → merdianal-L<sub>3</sub>Ir typically > 80% yield, XH = acetylacetone
Surprisingly, the photophysics of the meridianal isomers is different from that of the facial forms. This can be seen in the details of the spectra discussed below, which show a marked red shift and broadening in the meridianal isomer relative to its facial counterpart The emission lines appear as if a red band has been added to the and characteristic of the facial-L<sub>3</sub>Ir. The structure of the meridianal isomer is similar to those of L<sub>2</sub>IrX complexes, with respect, for example, to the arrangement of the N atoms of the ligands about Ir. Specifically, for L=ppy ligands, the nitrogen of the L ligand is trans in both mer-Ir(ppy)<sub>3</sub> and in (ppy)<sub>2</sub>Ir(acac). Further, one of the L ligands for the mer-L<sub>3</sub>Ir complexes has the same coordination as the X ligand of L<sub>2</sub>IrX complexes. In order to illustrate this point a model of mer-Ir(ppy)<sub>3</sub> is shown next to (ppy)<sub>2</sub>Ir(acac) in <figref idref="f0003">Figure 4</figref>. One of the ppy ligands of mer-Ir(ppy)<sub>3</sub> is coordinated to the Ir center in the same geometry as the acac ligand of (ppy)<sub>2</sub>Ir(acac).
The HOMO and LUMO energies of these L<sub>3</sub>Ir molecules are clearly affected by the choice of isomer. These energies are very important is controlling the current-voltage characteristics and lifetimes of OLEDs prepared with these phosphors.
The syntheses for the two isomers depicted in <figref idref="f0002">Figure 3</figref> are as follows.
Syntheses of meridianal isomers:
<b><i>mer</i>-Irbq:</b> 91 mg (0.078 mmol) of [Ir(bq)2Cl]2 dimer, 35.8 mg (0.2 mmol) of7,8-benzoquinoline, 0.02 ml of acetylacetone (ca. 0.2 mmol) and 83 mg (0.78 mmol) of sodium carbonate were boiled in 12 ml of 2-ethoxyethanol (used as received) for 14 hours in inert atmosphere. Upon cooling yellow-orange precipitate forms and is isolated by filtration and flash chromatography (silica gel, CH2Cl2) (yield 72%). 1H NMR (360 MHz, dichloromethane-d2),ppm: 8.31 (q,1H), 8.18 (q,1H), 8.12 (q,1H), 8.03(m,2H), 7.82 (m, 3H), 7.59 (m,2H), 7.47 (m,2H), 7.40 (d,1H), 7.17 (m,9H), 6.81 (d,1H), 6.57 (d,1H). MS,e/z: 727 (100%,M+). NMR spectrum in <figref idref="f0038">Figure 38</figref>.
<b>mer-Ir(tpy)<sub>3</sub>:</b> A solution of IrCl<sub>3</sub>•xH<sub>2</sub>O (0.301 g , 1.01 mmol), 2-(p-tolyl)pyridine (1.027 g, 6.069 mmol), 2,4-pentanedione (0.208 g, 2.08 mmol) and Na<sub>2</sub>CO<sub>3</sub> (0.350 g,, 3.30 mmol) in 2-ethoxyethanol (30 mL) was refluxed for 65 hours. The yellow-green mixture was cooled to room temperature and 20 mL of 1.0 M HCl was added to precipitate the product. The mixture was filtered and washed with 100 mL of 1.0 M HCl followed by 50 mL of methanol then dried and the solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and filtered through a short plug of silica. The solvent was removed under reduced pressure to yield the product as a yellow-orange powder (0.265 g, 38%).
V.A.3. Potential host molecules
This invention is directed toward the use of the above-noted dopants in a host phase. This host phase may be comprised of molecules comprising a carbazole moiety. Molecules which fall within the scope of the invention are included in the following. <chemistry id="chem0003" num="0003"><img file="EP2278637B2_D0003.tif" /></chemistry> [A line segment denotes possible substitution at any available carbon atom or atoms of the indicated by ring by alkyl or aryl groups.]
An additional preferred molecule with a carbazole functionality is 4,4'-N,N'-dicarbazole-biphenyl (CBP), which has the formula <chemistry id="chem0004" num="0004"><img file="EP2278637B2_D0004.tif" /></chemistry>
V.B.1. Utilization in devices
The device structure that we chose to use is very similar to the standard vacuum deposited one. As an overview, a hole transporting layer ("HTL") is first deposited onto the ITO (indium tin oxide) coated glass substrate. For the device yielding 12% quantum efficiency, the HTL consisted of 30 nm (300 A) of NPD. Onto the NPD a thin film of the organometallic doped into a host matrix is deposited to form an emitter layer. In the example, the emitter layer was CBP with 12% by weight bis(2-phenylbenzothiazole) iridium acetylacetonate (termed "BTIr"); the layer thickness was 30 nm (300 Å). A blocking layer is deposited onto the emitter layer. The blocking layer consisted of bathcuproine ("BCP"), and the thickness was 20 nm (200 Å). An electron transport layer is deposited onto the blocking layer. The electron transport layer consisted of Alq3 of thickness 20nm. The device is finished by depositing a Mg-Ag electrode onto the electron transporting layer. This was of thickness 100nm. All of the depositions were carried out at a vacuum less than 5 X 10<sup>-5</sup> Torr. The devices were tested in air, without packaging.
When we apply a voltage between the cathode and the anode, holes are injected from ITO to NPD and transported by the NPD layer, while electrons are injected from MgAg to Alq and transported through Alq and BCP. Then holes and electrons are injected into EML and carrier recombination occurs in CBP, the excited states were formed, energy transfer to BTIr occurs and finally BTIr molecules are excited and decay radiatively.
As illustrated in <figref idref="f0004 f0005">Figure 5</figref>, the quantum efficiency of this device is 12% at a current density of about 0.01 mA/cm2.
Pertinent terms are as follows: <ul id="ul0002" list-style="none" compact="compact"><li>ITO is a transparent conducting phase of indium tin oxide which functions as an anode. ITO is a degenerate semiconductor formed by doping a wide band semiconductor. The carrier concentration of the ITO is in excess of 10<sup>19</sup>/cm<sup>3</sup>.</li><li>BCP is an exciton blocking and electron transport layer.</li><li>AIq3: electron injection layer.</li></ul> Other hole transport layer materials could be used. For example, TPD, a hole transport layer, can be used.
BCP functions as an electron transport layer and as an exciton blocking layer, which layer has a thickness of about 10 nm (100 Å). BCP is 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (also called bathocuproine) which has the formula <chemistry id="chem0005" num="0005"><img file="EP2278637B2_D0005.tif" /></chemistry>
The Alq3, which functions as an electron injection/electron transport layer has the following formula. <chemistry id="chem0006" num="0006"><img file="EP2278637B2_D0006.tif" /></chemistry>
In general, the doping level is varied to establish the optimum doping level.
V. B. 2. Incorporation of a fluorescent ligand into a phosphorescent complex
As noted above, fluorescent materials have certain advantages as emitters in devices. If the L ligand that is used in making the L<sub>2</sub>MX (for example, M=Ir) complex has a high fluorescent quantum efficiency, it is possible to use the strong spin orbit coupling of the Ir metal to efficiently intersystem cross in and out of the triplet states of the ligands. The concept is that the Ir makes the L ligand an efficient phosphorescent center. Using this approach, it is possible to take any fluorescent dye and make an efficient phosphorescent molecule from it (that is, L fluorescent but L<sub>2</sub>MX (M=Ir) phosphorescent).
As an example, we prepared a L<sub>2</sub>IrX wherein L=coumarin and X=acac. We refer to this as coumarin-6 ["C6Ir"]. The complex gives intense orange emission, whereas coumarin by itself emits green. Both coumarin and C6Ir spectra are given in the figures.
Other fluorescent dyes would be expected to show similar spectral shifts. Since the number of fluorescent dyes that have been developed for dye lasers and other applications is quite large, we expect that this approach would lead to a wide range of phosphorescent materials.
One needs a fluorescent dye with suitable functionality such that it can be metallated by the metal (for example, iridium) to make a 5 or 6 membered metallocycle. All of the L ligands we have studied to date have sp2 hybridized carbons and heterocyclic N atoms in the ligands, such that one can form a five membered ring on reacting with Ir.
V.B.3. Carrier trapping at X or L ligands
Potential degradation reactions, involving holes or electrons, can occur in the emitter layer. The resultant oxidation or reduction can alter the emitter, and degrade performance.
In order to get the maximum efficiency for phosphor doped OLEDs, it is important to control, the holes or electrons which lead to undesirable oxidation or reduction reactions. One way to do this is to trap carriers (holes or electrons) at the phosphorescent dopant. It may be beneficial to trap the carrier at a position remote from the atoms or ligands responsible for the phosphorescence. The carrier that is thus remotely trapped could readily recombine with the opposite carrier either intramolecularly or with the carrier from an adjacent molecule.
An example of a phosphor designed to trap holes is shown in <figref idref="f0006">Figure 6</figref>. The diarylamine group on the salicylanlide group is expected to have a HOMO level 200-300 mV above that of the lr complex (based on electrochemical measurements), leading to the holes being trapped exclusively at the amine groups. Holes will be readily trapped at the amine, but the emission from this molecule will come from MLCT and intraligand transitions from the Ir(phenylpyridine) system. An electron trapped on this molecule will most likely be in one of the pyridyl ligands. Intramolecular recombinagtion will lead to the formation of an exciton, largely in the Ir(phenylpyridine) system. Since the trapping site is on the X ligand, which is typically not involved extensively in the luminescent process, the presence of the trapping site will not greatly affect the emission energy for the complex. Related molecules can be designed in which electron carriers are trapped remoted to the L<sub>2</sub>Ir system.
V.B.4. Color Tuning
As found in the IrL<sub>3</sub> system, the emission color is strongly affected by the L ligand. This is consistent with the emission involving either MLCT or intraligand transitions. In all of the cases that we have been able to make both the tris complex (i.e., IrL<sub>3</sub>) and the L<sub>2</sub>IrX complex, the emission spectra are very similar. For example Ir(ppy)<sub>3</sub> and (ppy)<sub>2</sub>Ir(acac) (acronym = <b>PPIr)</b> give strong green emission with a λ<sub>max</sub> of 510 nm. A similar trend is seen in comparing Ir(BQ)<sub>3</sub> and Ir(thpy)<sub>3</sub> to their L<sub>2</sub>Ir(acac) derivatives, i.e. , in some cases, no significant shift in emission between the two complexes.
However, in other cases, the choice of X ligand affects both the energy of emission and efficiency. Acac and salicylanilide L<sub>2</sub>IrX complexes give very similar spectra. The picolinic acid derivatives that we have prepared thus far show a small blue shift (15 nm) in their emission spectra relative to the acac and salicylanilide complexes of the same ligands. This can be seen in the spectra for <b>BTIr</b>, <b>BTIrsd</b> and <b>BTIrpic</b>. In all three of these complexes we expect that the emission becomes principally form MLCT and Intra-L transitions and the picolinic acid ligands are changing the energies of the metal orbitals and thus affecting the MLCT bands.
If an X ligand is used whose triplet levels fall lower in energy than the "L<sub>2</sub>Ir" framework, emission from the X ligand can be observed. This is the case for the <b>BTIRQ</b> complex. In this complex the emission intensity is very weak and centered at 650 nm. This was surprising since the emission for the BT ligand based systems are all near 550 nm. The emission in this case is almost completely form Q based transitions. The phosphorescence spectra for heavy metal quinolates (e.g. IrQ<sub>3</sub> or PtQ<sub>2</sub>) are centered at 650 nm. The complexes themselves emit with very low efficiency, < 0.01. Both the energy and efficiency of the L<sub>2</sub>IrQ material is consistent "X" based emission. If the emission form the X ligand or the "IrX" system were efficient this could have been a good red emitter. It is important to note that while all of the examples list here are strong "L" emitters, this does not preclude a good phosphor from being formed from "X" based emission.
The wrong choice of X ligand can also severally quench the emission from L<sub>2</sub>IrX complexes. Both hexafluoro-acac and diphenyl-acac complexes give either very weak emission of no emission at all when used as the X ligand is L<sub>2</sub>IrX complexes. The reasons why these ligands quench emission so strong are not at all clear, one of these ligands is more electron withdrawing than acac and the other more electron donating. We give the spectrum for <b>BQIrFA</b> in the figures. The emission spectrum for this complex is slightly shifted from <b>BQIr</b>, as expected for the much stronger electron withdrawing nature of the hexafluoroacac ligand. The emission intensity from <b>BQIrFA</b> is at least 2 orders of magnitude weaker than <b>BQIr.</b> We have not explored the complexes of these ligands due this severe quenching problem.
V. C. Other molecular depictions
CBP was used in the device described herein. The invention will work with other hole-transporting molecules known by one of ordinary skill to work in hole transporting layers of OLEDs.
Specifically, the invention will work with other molecules comprising a carbazole functionality, or an analogous aryl amine functionality.
V.D. Uses of device
The OLED of the present invention may be used in substantially any type of device which is comprised of an OLED, for example, in OLEDs that are incorporated into a larger display, a vehicle, a computer, a television, a printer, a large area wall, theater or stadium screen, a billboard or a sign.
The present invention as disclosed herein may be used in conjunction with co-pending applications: "High Reliability, High Efficiency, Integratable Organic Light Emitting Devices and Methods of Producing Same", Serial No. <patcit id="pcit0006" dnum="US08774119B"><text>08/774,119 (filed December 23, 1996</text></patcit>); "Novel Materials for Multicolor Light Emitting Diodes", Serial No. <patcit id="pcit0007" dnum="US08850264B"><text>08/850,264 (filed May 2, 1997</text></patcit>); "Electron Transporting and Light Emitting Layers Based on Organic Free Radicals", Serial No. <patcit id="pcit0008" dnum="US08774120B"><text>08/774,120 (filed December 23, 1996</text></patcit>)(issued as <patcit id="pcit0009" dnum="US5811833A"><text>US 5,811,833 on Sept. 22, 1998</text></patcit>); "Multicolor Display Devices", Serial No. <patcit id="pcit0010" dnum="US08772333B"><text>08/772,333 (filed December 23, 1996</text></patcit>); "Red-Emitting Organic Light Emitting Devices (OLED's)", Serial No. <patcit id="pcit0011" dnum="US08774087B"><text>08/774,087 (filed December 23, 1996</text></patcit>)(allowed); "Driving Circuit For Stacked Organic Light Emitting Devices", Serial No. <patcit id="pcit0012" dnum="US08792050B"><text>08/792,050 (filed February 3, 1997</text></patcit>)(issued as <patcit id="pcit0013" dnum="US5757139A"><text>US 5,757,139 on May 26, 1998</text></patcit>); "High Efficiency Organic Light Emitting Device Structures", Serial No. <patcit id="pcit0014" dnum="US08772332B"><text>08/772,332 (filed December 23, 1996</text></patcit>)(issued as <patcit id="pcit0015" dnum="US5834893A"><text>US 5,834,893 on Nov. 10, 1998</text></patcit>); "Vacuum Deposited, Non-Polymeric Flexible Organic Light Emitting Devices", Serial No. <patcit id="pcit0016" dnum="US08789319B"><text>08/789,319 (filed January 23, 1997</text></patcit>)(issued as <patcit id="pcit0017" dnum="US5844363A"><text>US 5,844,363 on Dec. 1, 1998</text></patcit>); "Displays Having Mesa Pixel Configuration". Serial No. <patcit id="pcit0018" dnum="US08794595B"><text>08/794,595 (filed February 3, 1997</text></patcit>); "Stacked Organic Light Emitting Devices", Serial No. <patcit id="pcit0019" dnum="US08792046B"><text>08/792,046 (filed February 3, 1997</text></patcit>)(issued as <patcit id="pcit0020" dnum="US5917280A"><text>US 5,917,280 on June 29, 1999</text></patcit>); "High Contrast Transparent Organic Light Emitting Devices", Serial No. <patcit id="pcit0021" dnum="US08792046B"><text>08/792,046 (filed February 3, 1997</text></patcit>); "High Contrast Transparent Organic Light Emitting Device Display", Serial No. <patcit id="pcit0022" dnum="US08821380B"><text>08/821,380 (filed March 20, 1997</text></patcit>); "Organic Light Emitting Devices Containing A Metal Complex of 5-Hydroxy-Quinoxaline as A Host Material", Serial No. <patcit id="pcit0023" dnum="US08838099B"><text>08/838,099 (filed April 15, 1997</text></patcit>)(issued as <patcit id="pcit0024" dnum="US5861219A"><text>US5,861,219 on Jan. 19, 1999</text></patcit>); "Light Emitting Devices Having High Brightness", Serial No. <patcit id="pcit0025" dnum="US08844353B"><text>08/844,353 (filed April 18, 1997</text></patcit>); "Organic Semiconductor Laser", Serial No. <patcit id="pcit0026" dnum="US08859468B"><text>08/859,468 (filed May 19, 1997</text></patcit>); "Saturated Full Color Stacked Organic Light Emitting Devices", Serial No. <patcit id="pcit0027" dnum="US08858994B"><text>08/858,994 (filed on May 20, 1997</text></patcit>)(issued as <patcit id="pcit0028" dnum="US5932895A"><text>US 5,932,895 on Aug. 3, 1999</text></patcit>); "Plasma Treatment of Conductive Layers", <patcit id="pcit0029" dnum="US9710252W" dnum-type="L"><text>PCT/US97/10252, (filed June 12, 1997</text></patcit>); "Novel Materials for Multicolor Light Emitting Diodes", Serial No. <patcit id="pcit0030" dnum="US08814976B"><text>08/814,976, (filed Mar. 11, 1997</text></patcit>); "Novel Materials for Multicolor Light Emitting Diodes", Serial No. <patcit id="pcit0031" dnum="US08771815B"><text>08/771,815, (filed Dec. 23, 1996</text></patcit>); "Patterning of Thin Films for the Fabrication of Organic Multi-color Displays", <patcit id="pcit0032" dnum="US9710289W" dnum-type="L"><text>PCT/US97/10289, (filed June 12,1997</text></patcit>), and "Double Heterostructure Infrared and Vertical Cavity Surface Emitting Organic Lasers", <patcit id="pcit0033" dnum="US9809480W" dnum-type="L"><text>PCT/US98/09480 filed May 8, 1998</text></patcit>; <patcit id="pcit0034" dnum="US5874803A"><text>US 5,874,803 issued Feb. 23, 1999</text></patcit>; <patcit id="pcit0035" dnum="US5707745A"><text>US 5,707,745 issued Jan. 13, 1998</text></patcit>; <patcit id="pcit0036" dnum="US5703436A"><text>US 5,703,436 issued Dec. 30, 1997</text></patcit>; and <patcit id="pcit0037" dnum="US5757026A"><text>US 5,757,026 issued May 26, 1998</text></patcit>
46 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46
Every citation, both waysCites: the store holds 0 of 1
| Reference | Relation |
|---|---|
| CALOGERO G. ET AL: "ABSORPTION SPECTRA; LUMINESCENCE PROPERTIES, AND ELECTROCHEMICAL BEHAVIOR OF CYCLOMETALATED IRIDIUM (III) AND RHODIUM (III) COMPLEXES WITH A BIS(PYRIDYL)TRIAZOLE LIGAND", INORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, EASTON, US, vol. 34, no. 3, 1 February 1995 (1995-02-01), pages 541-545, XP002231208, ISSN: 0020-1669 | Non-patent |
| MARCO DI G ET AL: "LUMINESCENT MONONUCLEAR AND DINUCLEAR IRIDIUM(III) CYCLOMETALATED COMPLEXES IMMOBILIZED IN A POLYMERIC MATRIX AS SOLID-STATE OXYGEN SENSORS", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 70, no. 23, 1 December 1998 (1998-12-01), pages 5019-5023, XP000799212, ISSN: 0003-2700 | Non-patent |
| NEVE F ET AL: "SYNTHESIS, STRUCTURE, PHOTOPHYSICAL PROPERTIES, AND REDOX BEHAVIOUR OF CYCLOMETALATED COMPLEXES OF IRIDIUM(III) WITH FUNCTIONALIZED 2,2'-BIPYRIDINES", INORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, EASTON, US, vol. 38, no. 10, 17 May 1999 (1999-05-17), pages 2250-2258, XP002295198, ISSN: 0020-1669, DOI: DOI:10.1021/IC981308I | Non-patent |
| WILDE A P ET AL: "Resolution and analysis of the components in dual emission of mixed-chelate/ ortho-metalate complexes of Iridium(III)", JOURNAL OF PHYSICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 95, 1 January 1991 (1991-01-01), pages 629-634, XP002315391, ISSN: 0022-3654, DOI: DOI:10.1021/J100155A026 | Non-patent |
143 members in 13 offices
Priority claims16
| Document | Office | Kind | Date |
|---|---|---|---|
| 452346 | United States of America | – | |
| 45234699 | United States of America | A | |
| 45234699 | United States of America | A | |
| 0032511 | United States of America | W | |
| 0032511 | United States of America | W | |
| 00980863 | European Patent Office (EPO) | A | |
| 00980863 | European Patent Office (EPO) | A | |
| 08003327 | European Patent Office (EPO) | A | |
| 08003327 | European Patent Office (EPO) | A | |
| 009808635 | – | – | – |
| 080033277 | – | – | – |
| 452346 | – | – | – |
| EP20000980863 | – | – | – |
| EP20080003327 | – | – | – |
| US19990452346 | – | – | – |
| WO2000US32511 | – | – | – |
Members143
| Document | Office | Kind | |
|---|---|---|---|
| WO0016593A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5921699A | Australia | A | |
| US6097147A | United States of America | A | |
| WO0057676A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3908400A | Australia | A | |
| WO0070655A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5004700A | Australia | A | |
| AU5004700A | Australia | A | |
| WO0141512A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1807201A | Australia | A | |
| EP1116417A1 | European Patent Office (EPO) | A1 | |
| KR20010079818A | Republic of Korea | A | |
| KR20020004982A | Republic of Korea | A | |
| BR0010424A | Brazil | A | |
| EP1181842A1 | European Patent Office (EPO) | A1 | |
| US2002034656A1 | United States of America | A1 | |
| BR0009215A | Brazil | A | |
| BR0009215A | Brazil | A | |
| CN1350768A | China | A | |
| KR20020042763A | Republic of Korea | A | |
| IL146242A0 | Israel | A0 | |
| IL146242D0 | Israel | D0 | |
| JP2002525808A | Japan | A | |
| TW500787B | Taiwan Province of China | B | |
| KR20020070299A | Republic of Korea | A | |
| EP1252803A1 | European Patent Office (EPO) | A1 | |
| JP2002540572A | Japan | A | |
| US2003017361A1 | United States of America | A1 | |
| EP1252803A4 | European Patent Office (EPO) | A4 | |
| CN1413426A | China | A | |
| JP2003515897A | Japan | A | |
| JP2003526876A | Japan | A | |
| TW581762B | Taiwan Province of China | B | |
| TW200407054A | Taiwan Province of China | A | |
| WO0070655A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1449238A2 | European Patent Office (EPO) | A2 | |
| US6830828B2 | United States of America | B2 | |
| US2004262576A1 | United States of America | A1 | |
| CN1572029A | China | A | |
| EP1181842A4 | European Patent Office (EPO) | A4 | |
| US6902830B2 | United States of America | B2 | |
| EP1449238A4 | European Patent Office (EPO) | A4 | |
| CN1224297C | China | C | |
| CN1226902C | China | C | |
| JP2005344124A | Japan | A | |
| IN1348MU2001A | India | A | |
| IN1348MU2001A | India | A | |
| US2006029829A1 | United States of America | A1 | |
| US7001536B2 | United States of America | B2 | |
| CN1840607A | China | A | |
| EP1449238B1 | European Patent Office (EPO) | B1 | |
| AT344532T | Austria | T | |
| ATE344532T1 | Austria | T1 | |
| EP1729327A1 | European Patent Office (EPO) | A1 | |
| DE60031729D1 | Germany | D1 | |
| KR100698964B1 | Republic of Korea | B1 | |
| KR20070065917A | Republic of Korea | A | |
| KR100744199B1 | Republic of Korea | B1 | |
| KR20070086623A | Republic of Korea | A | |
| KR20070087061A | Republic of Korea | A | |
| DE60031729T2 | Germany | T2 | |
| JP2007254755A | Japan | A | |
| JP3992929B2 | Japan | B2 | |
| US7291406B2 | United States of America | B2 | |
| US2007296332A1 | United States of America | A1 | |
| KR100794975B1 | Republic of Korea | B1 | |
| KR20080027968A | Republic of Korea | A | |
| IL146242A | Israel | A | |
| EP1933395A1 | European Patent Office (EPO) | A1 | |
| KR100840637B1 | Republic of Korea | B1 | |
| CN100407448C | China | C | |
| TWI300092B | Taiwan Province of China | B | |
| CN101312235A | China | A | |
| KR20080103112A | Republic of Korea | A | |
| EP1116417A4 | European Patent Office (EPO) | A4 | |
| KR100890980B1 | Republic of Korea | B1 | |
| US7537844B2 | United States of America | B2 | |
| US2009209760A1 | United States of America | A1 | |
| KR100913568B1 | Republic of Korea | B1 | |
| JP2009224795A | Japan | A | |
| JP4357781B2 | Japan | B2 | |
| JP4358168B2 | Japan | B2 | |
| KR20090122930A | Republic of Korea | A | |
| KR100934420B1 | Republic of Korea | B1 | |
| KR100937470B1 | Republic of Korea | B1 | |
| KR100946314B1 | Republic of Korea | B1 | |
| JP2010070764A | Japan | A | |
| KR20100042665A | Republic of Korea | A | |
| CN101312235B | China | B | |
| CN1840607B | China | B | |
| EP1252803B1 | European Patent Office (EPO) | B1 | |
| AT484852T | Austria | T | |
| ATE484852T1 | Austria | T1 | |
| DE60045110D1 | Germany | D1 | |
| EP2270895A2 | European Patent Office (EPO) | A2 | |
| EP2278637A1 | European Patent Office (EPO) | A1 | |
| JP4619546B2 | Japan | B2 | |
| US7883787B2 | United States of America | B2 | |
| EP2270895A3 | European Patent Office (EPO) | A3 | |
| EP2306495A1 | European Patent Office (EPO) | A1 |
91 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Epo decision maintaining patent in amended form now finalR102 | R102 | DE | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU | APBU | EP | |
| Patent expired because of reaching the maximum lifetime of a patentExpiredMK | MK | BE | |
| Patent expiredExpiredMK9A | MK9A | IE | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Patent expired because of reaching the maximum lifetime of a patentExpiredMK | MK | NL | |
| Patent ceasedCeasedPL | PL | CH | |
| Expiry of rightR071 | R071 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Date of receipt of statement of grounds of an appeal modifiedAppealORIGINAL CODE: EPIDOSCNOA3OAPAL | APAL | EP | |
| Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ | APBQ | EP | |
| Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ | APBQ | EP | |
| Appeal reference recordedAppealORIGINAL CODE: EPIDOSNREFNOAPBM | APBM | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH | APAH | EP | |
| Appeal reference recordedAppealORIGINAL CODE: EPIDOSNREFNOAPBM | APBM | EP | |
| Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP | APBP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Name/firm changedPFA | PFA | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Opposition filed against patentOppositionR026 | R026 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| New agentNV | NV | CH | |
| Reference to at number (ep patent enters austrian national phase)REF | REF | AT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Observations by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2278637
- Publication, DOCDB
- 2278637
- Publication, EPODOC
- EP2278637
- Application
- 101816643
- Application, DOCDB
- 10181664
- Application, EPODOC
- EP20100181664
Titles3
- German
- Komplexe der Form L2MX
- English
- Complexes of form L2MX
- French
- Complexes de formule L2MX
Classification
- CPC, 13
- C07D209/86
- C09K11/025
- C09K11/06
- H10K85/631
- H10K85/636
- H10K85/657
- H10K85/324
- H10K85/342
- H10K50/11
- H10K2101/10
- C09K2211/185
- H10K50/00
- C07F15/0033
- IPC, 5
- H01L51 30
- C07D209 86
- C07F15 00
- C09K11 06
- H10K99 00
Designated states1
- Contracting states, 1
- Türkiye
